If Two Heads Are Better Than One….

…..then the combined minds of the National Institutes of Health, ten major drug companies, and seven nonprofit groups ought to be able to make some progress.  This unique collaboration plans to target treatment development for lupus, rheumatoid arthritis, Alzheimer’s, and Type 2 diabetes over the next 5 years.  The group were compelled to cooperation for different reasons: major drug companies have invested and lost in many promising treatments while other groups are inundated in biological data.  Hopefully, by their powers combined, effective treatment option for these debilitating diseases.

Image

(NIH Clinical Research Center from Wikicommons)

Read more about why these disorders were selected, the reasons for the joint effort, and more at the New York Times: http://www.nytimes.com/2014/02/05/health/nih-joins-drug-makers-and-nonprofits-on-stubborn-diseases.html?hp&_r=1.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s